NCT05268224 - A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue | Biotech Hunter

Enrollment

1,500

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions

Breast Cancer Screening

Interventions

DIAGNOSTIC_TEST

Schirmer Strip

A tear-based screening assay for breast cancer developed and validated by Namida Lab, Inc., a high complexity CLIA-certified lab. It consists of two parts: tear sample collection using a Schirmer Strip and a clinical lab-developed test that measures protein biomarkers for breast cancer screening.

Trial Locations (1)

72703

RECRUITING

Namida Lab, Fayetteville